Merci
Une erreur s'est produite lors de la tentative d'envoi de votre message. Veuillez réessayer plus tard.

The content of Module Four was sourced from the following:

  • Adrion, E. R., Aucott, J., Lemke, K. W., & Weiner, J. P. (2015). Health care costs, utilization and patterns of care following Lyme disease. PloS One, 10(2), e0116767.
  • Ali, A., Vitulano, L., Lee, R., Weiss, T. R., & Colson, E. R. (2014). Experiences of patients identifying with chronic Lyme disease in the healthcare system: A qualitative study. BMC Family Practice, 15(79). https://doi.org/10.1186/1471-2296-15-7
  • Allan, B., & Smylie, J. (2015). First Peoples, second class treatment: The role of racism in the health and well-being of Indigenous Peoples in Canada. Wellesley Institute. https://www.wellesleyinstitute.com/wp-content/uploads/2015/02/Summary-First-Peoples-Second-Class-Treatment-Final.pdf
  • Association of Medical Microbiology and Infectious Diseases Canada (2019). AMMI Canada position statement on the diagnosis and treatment of people with persistent symptoms that have been attributed to Lyme disease. Retrieved from https://www.ammi.ca/Content/03.17.19%20AMMI%20Canada%20Position%20Statement%20%28EN%29.pdf
  • Aucott J. N., Rebman A. W., Crowder L. A., & Kortte K. B. (2013). Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here? Quality of Life Research, 22, 75-84. Doi: 10.1007/s11136-012-0126-6
  • Beaulieu, L. (2020). Dévoiler l’expérience et la réalité contextuelle des personnes atteintes de la maladie de Lyme chronique (MLC) au Canada Atlantique – Ethnographie critique (unpublished Master’s dissertation). Université de Moncton: Moncton NB.
  • Berger, J. J. & Hayes, B. K. (2018). Tick-borne disease working group: 2018 Report to Congress. Department of Health and Human Services. https://www.hhs.gov/sites/default/files/tbdwg-report-to-congress-2018.pdf
  • Borchers, A. T., Keen, C. L., Huntley, A. C., & Gershwin, M. E. (2015). Lyme disease: A rigorous review of diagnostic criteria and treatment. Journal of Autoimmunity, 57, 82-115. https://doi.org/10.1016/j.jaut.2014.09.004
  • Boudreau, C.R., Lloyd, V.K., & Gould, O.N. (2018). Motivations and experiences of Canadians seeking treatment for Lyme disease outside of the conventional Canadian health-care system. Journal of Patient Experience, 5(2), 120-126. doi: https://doi.org/10.1177/2374373517736385
  • Bransfield, R.C. (2017). Suicide and Lyme and associated diseases. Neuropsychiatric Disease and Treatment, 13, 1575-1587. doi: 10.2147/NDT.S136137
  • Butler T. (2017). The Jarisch-Herxheimer reaction after antibiotic treatment of spirochetal infections: A review of recent cases and our understanding of pathogenesis. The American Journal of Tropical Medicine and Hygiene, 96(1), 46–52. https://doi.org/10.4269/ajtmh.16-0434
  • Cameron, B. L., Pilar Carmargo Plazas, M., Salas, A. S., Bourque Bearskin, R. L., & Hungler, K. (2014). Understanding inequalities in access to health care services for aboriginal people: A call for nursing action. Advances in Nursing Science, 37(3), E1-E16. doi: 10.1097/ANS.0000000000000039
  • Campbell-Lendrum, D., Manga, L., Bagayoko, M., & Sommerfeld, J. (2015). Climate change and vector-borne diseases: what are the implications for public health research and policy? Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 370(1665), 20130552. https://doi.org/10.1098/rstb.2013.0552
  • CanLyme. (n.d). Lyme Diagnosis. Retrieved January 19, 2021 https://canlyme.com/just-diagnosed/
  • Cardenas-de la Garza, J. A., De la Cruz-Valadez, E., Ocampo-Candiani, J., & Welsh, O. (2019). Clinical spectrum of Lyme disease. European Journal of Clinical Microbiology & Infectious Diseases, 38(2), 201-208. doi: 10.1007/s10096-018-3417-1
  • Centers for Disease Control and Prevention (2018). West Nile virus: Treatment and prevention. https://www.cdc.gov/westnile/healthcareproviders/healthCareProviders-TreatmentPrevention.html
  • Centers for Disease Control and Prevention (2019). Post-treatment Lyme disease syndrome. https://www.cdc.gov/lyme/postlds/index.html
  • Centers for Disease Control and Prevention (2020a). Lyme disease frequently asked questions (FAQ). https://www.cdc.gov/lyme/faq/index.html
  • Centers for Disease Control and Prevention (2020b). Signs and symptoms of untreated Lyme disease. https://www.cdc.gov/lyme/signs_symptoms/index.html
  • Centres for Disease Control and Prevention. (n.d.). West Nile Virus (WNV) fact sheet. https://www.cdc.gov/westnile/resources/pdfs/wnvFactsheet_508.pdf
  • Chaaya, G., Jaller-Char, J. J., & Ali, S. K. (2016). Beyond the bull’s eye: Recognizing Lyme disease. Journal of Family Practice, 65(6), 373-380. https://cdn.mdedge.com/files/s3fs-public/issues/articles/content_3a7d8058cb82b990e7_JFP_06506_Article2.PDF
  • Cook, M. J. (2015). Lyme borreliosis: A review of data on transmission time after tick attachment. International Journal of General Medicine, 8, 1-8. doi: 10.2147/IJGM.S73791
  • Davidsson, M. (2018). The financial implications of a well-hidden and ignored chronic Lyme disease pandemic. Healthcare, 6(16), 1-50. doi:10.3390/healthcare6010016
  • Drew, D. & Hewitt, H. (2006). A qualitative approach to understanding patients’ diagnosis of Lyme disease. Public Health Nursing, 23(1), 20-26. https://doi.org/10.1111/j.0737-1209.2006.230104.x
  • Fallon, B. A., Zubcevik, N., Bennett, C., Doshi, S., Rebman, A. W., Kishon, R., Moeller, J. R., Octavien, N. R., & Aucott, J. N. (2019). The General Symptom Questionnaire-30 (GSQ-30): A brief measure of multi-system symptom burden in Lyme disease. Frontiers in Medicine, 6, 283. https://doi.org/10.3389/fmed.2019.00283
  • Feng, J., Li, T., Yee, R., Yuan, Y., Bai, C., Cai, M., Shi, W., Embers, M., Brayton, C., Saeki, H., Gabrielson, K., & Zhang, Y. (2019). Stationary phase persister/biofilm microcolony of Borrelia burgdorferi causes more severe disease in a mouse model of Lyme arthritis: implications for understanding persistence, Post-treatment Lyme Disease Syndrome (PTLDS), and treatment failure. Discovery Medicine, 27(148), 125–138.
  • Furgal, C. (2010). Health impacts of climate change in Canada’s North. In Seguin, J. (Ed). Human health in a changing climate: A Canadian assessment of vulnerabilities and adaptive capacity (pp. 307-366). Ottawa, ON: Health Canada.
  • Goodman, A., Fleming, K., Markwick, N., Morrison, T., Lagimodiere, L., Kerr, T., & Western Aboriginal Harm Reduction Society (2017). “They treated me like crap and I know it was because I was Native”: The healthcare experiences of Aboriginal peoples living in Vancouver’s inner city. Social Science & Medicine, 178, 87-94. https://doi.org/10.1016/j.socscimed.2017.01.053
  • Government of Alberta (2019). Lyme disease. Retrieved from https://myhealth.alberta.ca/health/pages/conditions.aspx?Hwid=hw77226
  • Government of Canada (2015). For health professionals: West Nile virus https://www.canada.ca/en/public-health/services/diseases/west-nile-virus/health-professionals-treating-west-nile-virus.html
  • Government of Canada (2016). Treatment of West Nile virus. https://www.canada.ca/en/public-health/services/diseases/west-nile-virus/treatment-west-nile-virus.html
  • Government of Canada (2017a). What are the symptoms of Lyme disease? https://www.canada.ca/en/public-health/services/diseases/lyme-disease/symptoms-lyme-disease.html
  • Government of Canada (2017b). Treatment of Lyme disease. https://www.canada.ca/en/public-health/services/diseases/lyme-disease/treatment-lyme-disease.html
  • Government of Canada (2017c). Lyme disease in Canada: A federal framework. https://www.canada.ca/en/public-health/services/publications/diseases-conditions/lyme-disease-canada-federal-framework.html
  • Government of Canada (2018). National case definition: Lyme disease. https://www.canada.ca/en/public-health/services/diseases/lyme-disease/health-professionals-lyme-disease/national-case-definition.html
  • Government of Canada (2019). Lyme disease and pregnancy. https://www.canada.ca/en/public-health/services/diseases/lyme-disease.html
  • Government of Canada (2020a). Travel-related diseases. https://travel.gc.ca/travelling/health-safety/diseases
  • Government of Canada (2020b). For health professionals: Lyme disease. https://www.canada.ca/en/public-health/services/diseases/lyme-disease/health-professionals-lyme-disease.html
  • Government of Canada. (2020c). Reported cases from 1924 to 2018 in Canada – notifiable diseases on-line. https://dsol-smed.phac-aspc.gc.ca/dsol-smed/ndis/charts.php?c=pl
  • Hatchette, T.F., Davis, I., & Johnston, B.L. (2014). Lyme disease: Clinical diagnosis and treatment. Canadian Communicable Disease Report 40(11), 194-208. https://doi.org/10.14745.ccdr.v40i11a01
  • Hawkins, R. (2019). Dr. Ralph Hawkins, Canada’s renegade chronic Lyme disease doctor . Canadian Broadcast Corporation https://www.cbc.ca/player/play/1605847107683
  • Horrill, T., McMillan, D. E., Schultz, A. S., & Thompson, G. (2018). Understanding access to healthcare among Indigenous peoples: A comparative analysis of biomedical and postcolonial perspectives. Nursing Inquiry, 25(3), e12237. doi: 10.1111/nin.12237
  • International Lyme and Associated Disease Society (2014). Evidence Based Treatment Guidelines. https://www.ilads.org/patient-care/ilads-treatment-guidelines/
  • International Lyme and Associated Disease Society [ILADS]. (2021). Controversies & challenges in treating Lyme and other tick-borne diseases. https://www.ilads.org/research-literature/controversies-challenges/
  • Johnson, L., Shapiro, M., & Mankoff, J. (2018). Removing the mask of average treatment effects in chronic Lyme disease research using big data and subgroup analysis. Healthcare, 6(124), 1-20. http://www.mdpi.com/2227-9032/6/4/124
  • Johnson, L., Wilcox S., Mankoff, J., & Stricker R.B. (2014). Severity of chronic Lyme disease compared to other chronic conditions: A quality of life survey. PeerJ, 2, e322. DOI: 10.7717/peerj.322
  • Kuleš, J., Potocnakova, L., Bhide, K., Tomassone, L., Fuehrer, H. P., Horvatić, A., Galan, A., Guillemin, N., Nizic, P., Mrljak, V., & Bhide, M. (2017). The challenges and advances in diagnosis of vector-borne diseases: Where do we stand?. Vector-Borne and Zoonotic Diseases, 17(5), 285-296.
  • Lapum, J., St-Amant, O., Hughes, M., Petrie, P., Morrell, S., and Mistry, S. (2019). The complete subjective health assessment. Retrieved from https://ecampusontario.pressbooks.pub/healthassessment/
  • Lloyd, V. K., & Hawkins, R. G. (2018). Under-detection of Lyme disease in Canada. Healthcare 6(4): doi:10.3390/healthcare6040125.
  • Lyme Disease Task Force. (2018). Report of the Lyme disease and tick-borne illnesses task force. http://www.health.gov.on.ca/en/common/ministry/publications/reports/lyme_18/ldtf_final_report_2018.pdf
  • MacLeod, M. (2019, January 20). Mothers on a mission to prove Lyme disease can be passed to unborn child. CTV. https://www.ctvnews.ca/health/mothers-on-a-mission-to-prove-lyme-disease-can-be-passed-to-unborn-child-1.4261403
  • Marchese, N. M., & Primer, S. R. (2013). Targeting Lyme disease. Nursing 2019, 43(5), 28-33. doi: 10.1097/01.NURSE.0000428691.49098.16
  • Mathieu, K. & Karmali, M. (2016). Vector-borne diseases, climate change and healthy urban living: Next steps. Canadian Communicable Disease Report, 42, 219-21. https://doi.org/10.14745/ccdr.v42i10a13
  • Matthews, R. (2017). The cultural erosion of Indigenous people in health care. Canadian Medical Association Journal, 189(2), E78-E79. doi: 10.1503/cmaj.160167
  • McGhee, S., Visovksy, C., Zambroski, C., & Finnegan, A. (2018). Lyme disease: recognition and management for emergency nurses. Emergency Nurse, 26(3). https://www.researchgate.net/publication/326953784_Lyme_disease_Recognition_and_management_for_emergency_nurses
  • Moore, K. S. (2015). Lyme disease: Diagnosis, treatment guidelines, and controversy. The Journal for Nurse Practitioners, 11(1), 64-69. doi: https://doi.org/10.1016/j.nurpra.2014.09.021
  • Muise, G. M. (2019). Enabling cultural safety in Indigenous primary healthcare. Healthcare management Forum, 32(1), 25-31. Los Angeles, CA: SAGE Publications.
  • MyLymeData (2019). 2019 chart book – MyLymeData registry: Project of Lymedisease.org. Retrieved from lymedisease.org/2019-mylymedata-highlights.pdf
  • National Institute for Health and Care Excellence. (2018). Lyme disease: Recommendations. https://www.nice.org.uk/guidance/ng95
  • Nolan, L. (2020). How medical education is missing the bull’s-eye. New England Journal of Medicine, 382(26), 2489-2491. doi:10.1056/NEJMp1915891. www.nejm.org/doi/pdf/10.1056/NEJMp1915891?listPDF=true
  • Nursing Council of New Zealand. (2005). Guidelines for cultural safety, the Treaty of Waitangi and Maori Health in Nursing Education and Practice. Retrieved from www.nursingcouncil.org.nz
  • Oppong, J. R. (2020). Globalization of communicable diseases. International Encyclopedia of Human Geography, 6, 223-228. doi: 10.1016/B978-0-08-102295-5.10438-X
  • Palmieri, J. R., Kushwaha-Wagner, A., Bekele, A. M., Chang, J., Nguyen, A. et al. (2019). Missed diagnosis and the development of acute and late Lyme disease in dark skinned populations of Appalachia. Biomedical Journal of Scientific & Technical Research, 21(2), 15782-15787. doi: 10.26717/BJSTR.2019.21.003583
  • Patel, S., Brandon, N., Mabaya, G., & Phillips, L. (2019). Public Health Ontario: Diagnosing and managing early Lyme disease in Ontario. https://www.hqontario.ca/Events/Diagnosing-and-Managing-Early-Lyme-Disease-in-Ontario
  • Patton, S. & Phillips, B. (2018). Lyme disease: Diagnosis, treatment and prevention. American Journal of Nursing, 118(4), 38-45. doi: 10.1097/01.NAJ.0000532071.32468.f7
  • Punch, D. (2018). Ticking Lyme bomb. Registered Nurse Journal. Retrieved from https://rnao.ca/sites/rnao-ca/files/RNJ-MayJune2018_ticking_lyme_bomb.pdf
  • Raffetin, A., Saunier, A., Bouiller, K., Caraux-Paz, P., Eldin, C., Gallien, S., Jouenne, R., Belkacem, A., Salomon, J., Talagrand-Reboul, E. Jaulhac, B., & Grillon, A. (2020). Unconventional diagnostic tests for Lyme borreliosis: A systematic review. Clinical Microbiology and Infection, 26(1), 51-59. doi: https://doi.org/10.1016/j.cmi.2019.06.033
  • Rebman, A. W., & Aucott, J. N. (2020). Post-treatment Lyme disease as a model for persistent symptoms in Lyme disease. Frontiers in Medicine, 7(57). doi: 10.3389/fmed.2020.00057
  • Rebman, A. W., Bechtold, K. T., Yang, T., Mihm, E. A., Soloski, M. J., Novak, C. B., & Aucott, J. N. (2017). The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment Lyme disease syndrome. Frontiers in Medicine, 4, 224. doi: 10.3389/fmed.2017.00224
  • Scott, J. D., Clark, K. L., Foley, J. E., Anderson, J. F., Bierman, B. C., & Durden, L. A. (2018). Extensive distribution of the Lyme disease bacterium, Borrelia burgdorferi Sensu Lato, in multiple tick species parasitizing avian and mammalian hosts across Canada. Healthcare (Basel, Switzerland), 6(4), 131. https://doi.org/10.3390/healthcare6040131
  • Shor, W., Green C., Szantyr B., Phillips S., Liegner K., Burrascano J., Bransfield R., & Maloney W.L. (2019). Chronic Lyme disease: An evidence-based definition by the ILADS working group. Antibiotics, 8, 269. doi: 10.3390/antiobiotics8040269
  • Smith, G. N., Moore, K. M., Hatchette, T. F., Nicholson, J., Bowie, W., Langley, J. M. (2020). Committee opinion no.399: Management of tick bites and Lyme disease during pregnancy. Journal of Obstetrics and Gynaecology Canada, 42(5), 644.
  • Statistics Canada. (2019). Travel between Canada and other countries, December 2019. https://www150.statcan.gc.ca/n1/daily-quotidien/200221/dq200221b-eng.htm
  • Truth and Reconciliation Commission of Canada. (2015). Honouring the truth, reconciling for the future: Summary of the final report of the Truth and Reconciliation Commission of Canada. Truth and Reconciliation Commission of Canada. http://nctr.ca/assets/reports/Final%20Reports/Executive_Summary_English_Web.pdf
  • Waddell, L. A., Greig, J., Lindsay, L. R., Hinckley, A. F., & Ogden, N. H. (2018). A systematic review on the impact of gestational Lyme disease in humans on the fetus and newborn. PloS One, 13(11). doi: https://doi.org/10.1371/journal.pone.0207067
  • Ward, C., Branch, C., & Fridkin A. (2016). What is Indigenous cultural safety—and why should I care about it? Visions Journal, 11 (4). Retrieved from https://www.heretohelp.bc.ca/visions/indigenous-people-vol11/what-indigenous-cultural-safety-and-why-should-i-care-about-it#:~:text=This%20is%20the%20heart%20of,as%20these%20relate%20to%20Indigenous
  • World Health Organization [WHO]. (2020). WHOQOL: Measuring quality of life. Retrieved from https://www.who.int/toolkits/whoqol
  • World Health Organization. (n.d.). West Nile virus in the WHO European region. Retrieved from https://www.euro.who.int/__data/assets/pdf_file/0020/246170/Fact-sheet-West-Nile-virus-Eng.pdf
  • Wormser, G., Dattwyler, R., Shapiro, E., Halperin, J., Steere, A., Klempner, M., Krause, P., Bakken, J., Strle, F., Stanek, G., Bockenstedt, L., Fish, D., Dumler, S., & Nadelman, R. (2006). The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases, 43(9), 1089-1134. https://doi.org/10.1086/508667
Merci
Une erreur s'est produite lors de la tentative d'envoi de votre message. Veuillez réessayer plus tard.

The content of Module Four was sourced from the following:

  • Adrion, E. R., Aucott, J., Lemke, K. W., & Weiner, J. P. (2015). Health care costs, utilization and patterns of care following Lyme disease. PloS One, 10(2), e0116767.
  • Ali, A., Vitulano, L., Lee, R., Weiss, T. R., & Colson, E. R. (2014). Experiences of patients identifying with chronic Lyme disease in the healthcare system: A qualitative study. BMC Family Practice, 15(79). https://doi.org/10.1186/1471-2296-15-7
  • Allan, B., & Smylie, J. (2015). First Peoples, second class treatment: The role of racism in the health and well-being of Indigenous Peoples in Canada. Wellesley Institute. https://www.wellesleyinstitute.com/wp-content/uploads/2015/02/Summary-First-Peoples-Second-Class-Treatment-Final.pdf
  • Association of Medical Microbiology and Infectious Diseases Canada (2019). AMMI Canada position statement on the diagnosis and treatment of people with persistent symptoms that have been attributed to Lyme disease. Retrieved from https://www.ammi.ca/Content/03.17.19%20AMMI%20Canada%20Position%20Statement%20%28EN%29.pdf
  • Aucott J. N., Rebman A. W., Crowder L. A., & Kortte K. B. (2013). Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here? Quality of Life Research, 22, 75-84. Doi: 10.1007/s11136-012-0126-6
  • Beaulieu, L. (2020). Dévoiler l’expérience et la réalité contextuelle des personnes atteintes de la maladie de Lyme chronique (MLC) au Canada Atlantique – Ethnographie critique (unpublished Master’s dissertation). Université de Moncton: Moncton NB.
  • Berger, J. J. & Hayes, B. K. (2018). Tick-borne disease working group: 2018 Report to Congress. Department of Health and Human Services. https://www.hhs.gov/sites/default/files/tbdwg-report-to-congress-2018.pdf
  • Borchers, A. T., Keen, C. L., Huntley, A. C., & Gershwin, M. E. (2015). Lyme disease: A rigorous review of diagnostic criteria and treatment. Journal of Autoimmunity, 57, 82-115. https://doi.org/10.1016/j.jaut.2014.09.004
  • Boudreau, C.R., Lloyd, V.K., & Gould, O.N. (2018). Motivations and experiences of Canadians seeking treatment for Lyme disease outside of the conventional Canadian health-care system. Journal of Patient Experience, 5(2), 120-126. doi: https://doi.org/10.1177/2374373517736385
  • Bransfield, R.C. (2017). Suicide and Lyme and associated diseases. Neuropsychiatric Disease and Treatment, 13, 1575-1587. doi: 10.2147/NDT.S136137
  • Butler T. (2017). The Jarisch-Herxheimer reaction after antibiotic treatment of spirochetal infections: A review of recent cases and our understanding of pathogenesis. The American Journal of Tropical Medicine and Hygiene, 96(1), 46–52. https://doi.org/10.4269/ajtmh.16-0434
  • Cameron, B. L., Pilar Carmargo Plazas, M., Salas, A. S., Bourque Bearskin, R. L., & Hungler, K. (2014). Understanding inequalities in access to health care services for aboriginal people: A call for nursing action. Advances in Nursing Science, 37(3), E1-E16. doi: 10.1097/ANS.0000000000000039
  • Campbell-Lendrum, D., Manga, L., Bagayoko, M., & Sommerfeld, J. (2015). Climate change and vector-borne diseases: what are the implications for public health research and policy? Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 370(1665), 20130552. https://doi.org/10.1098/rstb.2013.0552
  • CanLyme. (n.d). Lyme Diagnosis. Retrieved January 19, 2021 https://canlyme.com/just-diagnosed/
  • Cardenas-de la Garza, J. A., De la Cruz-Valadez, E., Ocampo-Candiani, J., & Welsh, O. (2019). Clinical spectrum of Lyme disease. European Journal of Clinical Microbiology & Infectious Diseases, 38(2), 201-208. doi: 10.1007/s10096-018-3417-1
  • Centers for Disease Control and Prevention (2018). West Nile virus: Treatment and prevention. https://www.cdc.gov/westnile/healthcareproviders/healthCareProviders-TreatmentPrevention.html
  • Centers for Disease Control and Prevention (2019). Post-treatment Lyme disease syndrome. https://www.cdc.gov/lyme/postlds/index.html
  • Centers for Disease Control and Prevention (2020a). Lyme disease frequently asked questions (FAQ). https://www.cdc.gov/lyme/faq/index.html
  • Centers for Disease Control and Prevention (2020b). Signs and symptoms of untreated Lyme disease. https://www.cdc.gov/lyme/signs_symptoms/index.html
  • Centres for Disease Control and Prevention. (n.d.). West Nile Virus (WNV) fact sheet. https://www.cdc.gov/westnile/resources/pdfs/wnvFactsheet_508.pdf
  • Chaaya, G., Jaller-Char, J. J., & Ali, S. K. (2016). Beyond the bull’s eye: Recognizing Lyme disease. Journal of Family Practice, 65(6), 373-380. https://cdn.mdedge.com/files/s3fs-public/issues/articles/content_3a7d8058cb82b990e7_JFP_06506_Article2.PDF
  • Cook, M. J. (2015). Lyme borreliosis: A review of data on transmission time after tick attachment. International Journal of General Medicine, 8, 1-8. doi: 10.2147/IJGM.S73791
  • Davidsson, M. (2018). The financial implications of a well-hidden and ignored chronic Lyme disease pandemic. Healthcare, 6(16), 1-50. doi:10.3390/healthcare6010016
  • Drew, D. & Hewitt, H. (2006). A qualitative approach to understanding patients’ diagnosis of Lyme disease. Public Health Nursing, 23(1), 20-26. https://doi.org/10.1111/j.0737-1209.2006.230104.x
  • Fallon, B. A., Zubcevik, N., Bennett, C., Doshi, S., Rebman, A. W., Kishon, R., Moeller, J. R., Octavien, N. R., & Aucott, J. N. (2019). The General Symptom Questionnaire-30 (GSQ-30): A brief measure of multi-system symptom burden in Lyme disease. Frontiers in Medicine, 6, 283. https://doi.org/10.3389/fmed.2019.00283
  • Feng, J., Li, T., Yee, R., Yuan, Y., Bai, C., Cai, M., Shi, W., Embers, M., Brayton, C., Saeki, H., Gabrielson, K., & Zhang, Y. (2019). Stationary phase persister/biofilm microcolony of Borrelia burgdorferi causes more severe disease in a mouse model of Lyme arthritis: implications for understanding persistence, Post-treatment Lyme Disease Syndrome (PTLDS), and treatment failure. Discovery Medicine, 27(148), 125–138.
  • Furgal, C. (2010). Health impacts of climate change in Canada’s North. In Seguin, J. (Ed). Human health in a changing climate: A Canadian assessment of vulnerabilities and adaptive capacity (pp. 307-366). Ottawa, ON: Health Canada.
  • Goodman, A., Fleming, K., Markwick, N., Morrison, T., Lagimodiere, L., Kerr, T., & Western Aboriginal Harm Reduction Society (2017). “They treated me like crap and I know it was because I was Native”: The healthcare experiences of Aboriginal peoples living in Vancouver’s inner city. Social Science & Medicine, 178, 87-94. https://doi.org/10.1016/j.socscimed.2017.01.053
  • Government of Alberta (2019). Lyme disease. Retrieved from https://myhealth.alberta.ca/health/pages/conditions.aspx?Hwid=hw77226
  • Government of Canada (2015). For health professionals: West Nile virus https://www.canada.ca/en/public-health/services/diseases/west-nile-virus/health-professionals-treating-west-nile-virus.html
  • Government of Canada (2016). Treatment of West Nile virus. https://www.canada.ca/en/public-health/services/diseases/west-nile-virus/treatment-west-nile-virus.html
  • Government of Canada (2017a). What are the symptoms of Lyme disease? https://www.canada.ca/en/public-health/services/diseases/lyme-disease/symptoms-lyme-disease.html
  • Government of Canada (2017b). Treatment of Lyme disease. https://www.canada.ca/en/public-health/services/diseases/lyme-disease/treatment-lyme-disease.html
  • Government of Canada (2017c). Lyme disease in Canada: A federal framework. https://www.canada.ca/en/public-health/services/publications/diseases-conditions/lyme-disease-canada-federal-framework.html
  • Government of Canada (2018). National case definition: Lyme disease. https://www.canada.ca/en/public-health/services/diseases/lyme-disease/health-professionals-lyme-disease/national-case-definition.html
  • Government of Canada (2019). Lyme disease and pregnancy. https://www.canada.ca/en/public-health/services/diseases/lyme-disease.html
  • Government of Canada (2020a). Travel-related diseases. https://travel.gc.ca/travelling/health-safety/diseases
  • Government of Canada (2020b). For health professionals: Lyme disease. https://www.canada.ca/en/public-health/services/diseases/lyme-disease/health-professionals-lyme-disease.html
  • Government of Canada. (2020c). Reported cases from 1924 to 2018 in Canada – notifiable diseases on-line. https://dsol-smed.phac-aspc.gc.ca/dsol-smed/ndis/charts.php?c=pl
  • Hatchette, T.F., Davis, I., & Johnston, B.L. (2014). Lyme disease: Clinical diagnosis and treatment. Canadian Communicable Disease Report 40(11), 194-208. https://doi.org/10.14745.ccdr.v40i11a01
  • Hawkins, R. (2019). Dr. Ralph Hawkins, Canada’s renegade chronic Lyme disease doctor . Canadian Broadcast Corporation https://www.cbc.ca/player/play/1605847107683
  • Horrill, T., McMillan, D. E., Schultz, A. S., & Thompson, G. (2018). Understanding access to healthcare among Indigenous peoples: A comparative analysis of biomedical and postcolonial perspectives. Nursing Inquiry, 25(3), e12237. doi: 10.1111/nin.12237
  • International Lyme and Associated Disease Society (2014). Evidence Based Treatment Guidelines. https://www.ilads.org/patient-care/ilads-treatment-guidelines/
  • International Lyme and Associated Disease Society [ILADS]. (2021). Controversies & challenges in treating Lyme and other tick-borne diseases. https://www.ilads.org/research-literature/controversies-challenges/
  • Johnson, L., Shapiro, M., & Mankoff, J. (2018). Removing the mask of average treatment effects in chronic Lyme disease research using big data and subgroup analysis. Healthcare, 6(124), 1-20. http://www.mdpi.com/2227-9032/6/4/124
  • Johnson, L., Wilcox S., Mankoff, J., & Stricker R.B. (2014). Severity of chronic Lyme disease compared to other chronic conditions: A quality of life survey. PeerJ, 2, e322. DOI: 10.7717/peerj.322
  • Kuleš, J., Potocnakova, L., Bhide, K., Tomassone, L., Fuehrer, H. P., Horvatić, A., Galan, A., Guillemin, N., Nizic, P., Mrljak, V., & Bhide, M. (2017). The challenges and advances in diagnosis of vector-borne diseases: Where do we stand?. Vector-Borne and Zoonotic Diseases, 17(5), 285-296.
  • Lapum, J., St-Amant, O., Hughes, M., Petrie, P., Morrell, S., and Mistry, S. (2019). The complete subjective health assessment. Retrieved from https://ecampusontario.pressbooks.pub/healthassessment/
  • Lloyd, V. K., & Hawkins, R. G. (2018). Under-detection of Lyme disease in Canada. Healthcare 6(4): doi:10.3390/healthcare6040125.
  • Lyme Disease Task Force. (2018). Report of the Lyme disease and tick-borne illnesses task force. http://www.health.gov.on.ca/en/common/ministry/publications/reports/lyme_18/ldtf_final_report_2018.pdf
  • MacLeod, M. (2019, January 20). Mothers on a mission to prove Lyme disease can be passed to unborn child. CTV. https://www.ctvnews.ca/health/mothers-on-a-mission-to-prove-lyme-disease-can-be-passed-to-unborn-child-1.4261403
  • Marchese, N. M., & Primer, S. R. (2013). Targeting Lyme disease. Nursing 2019, 43(5), 28-33. doi: 10.1097/01.NURSE.0000428691.49098.16
  • Mathieu, K. & Karmali, M. (2016). Vector-borne diseases, climate change and healthy urban living: Next steps. Canadian Communicable Disease Report, 42, 219-21. https://doi.org/10.14745/ccdr.v42i10a13
  • Matthews, R. (2017). The cultural erosion of Indigenous people in health care. Canadian Medical Association Journal, 189(2), E78-E79. doi: 10.1503/cmaj.160167
  • McGhee, S., Visovksy, C., Zambroski, C., & Finnegan, A. (2018). Lyme disease: recognition and management for emergency nurses. Emergency Nurse, 26(3). https://www.researchgate.net/publication/326953784_Lyme_disease_Recognition_and_management_for_emergency_nurses
  • Moore, K. S. (2015). Lyme disease: Diagnosis, treatment guidelines, and controversy. The Journal for Nurse Practitioners, 11(1), 64-69. doi: https://doi.org/10.1016/j.nurpra.2014.09.021
  • Muise, G. M. (2019). Enabling cultural safety in Indigenous primary healthcare. Healthcare management Forum, 32(1), 25-31. Los Angeles, CA: SAGE Publications.
  • MyLymeData (2019). 2019 chart book – MyLymeData registry: Project of Lymedisease.org. Retrieved from lymedisease.org/2019-mylymedata-highlights.pdf
  • National Institute for Health and Care Excellence. (2018). Lyme disease: Recommendations. https://www.nice.org.uk/guidance/ng95
  • Nolan, L. (2020). How medical education is missing the bull’s-eye. New England Journal of Medicine, 382(26), 2489-2491. doi:10.1056/NEJMp1915891. www.nejm.org/doi/pdf/10.1056/NEJMp1915891?listPDF=true
  • Nursing Council of New Zealand. (2005). Guidelines for cultural safety, the Treaty of Waitangi and Maori Health in Nursing Education and Practice. Retrieved from www.nursingcouncil.org.nz
  • Oppong, J. R. (2020). Globalization of communicable diseases. International Encyclopedia of Human Geography, 6, 223-228. doi: 10.1016/B978-0-08-102295-5.10438-X
  • Palmieri, J. R., Kushwaha-Wagner, A., Bekele, A. M., Chang, J., Nguyen, A. et al. (2019). Missed diagnosis and the development of acute and late Lyme disease in dark skinned populations of Appalachia. Biomedical Journal of Scientific & Technical Research, 21(2), 15782-15787. doi: 10.26717/BJSTR.2019.21.003583
  • Patel, S., Brandon, N., Mabaya, G., & Phillips, L. (2019). Public Health Ontario: Diagnosing and managing early Lyme disease in Ontario. https://www.hqontario.ca/Events/Diagnosing-and-Managing-Early-Lyme-Disease-in-Ontario
  • Patton, S. & Phillips, B. (2018). Lyme disease: Diagnosis, treatment and prevention. American Journal of Nursing, 118(4), 38-45. doi: 10.1097/01.NAJ.0000532071.32468.f7
  • Punch, D. (2018). Ticking Lyme bomb. Registered Nurse Journal. Retrieved from https://rnao.ca/sites/rnao-ca/files/RNJ-MayJune2018_ticking_lyme_bomb.pdf
  • Raffetin, A., Saunier, A., Bouiller, K., Caraux-Paz, P., Eldin, C., Gallien, S., Jouenne, R., Belkacem, A., Salomon, J., Talagrand-Reboul, E. Jaulhac, B., & Grillon, A. (2020). Unconventional diagnostic tests for Lyme borreliosis: A systematic review. Clinical Microbiology and Infection, 26(1), 51-59. doi: https://doi.org/10.1016/j.cmi.2019.06.033
  • Rebman, A. W., & Aucott, J. N. (2020). Post-treatment Lyme disease as a model for persistent symptoms in Lyme disease. Frontiers in Medicine, 7(57). doi: 10.3389/fmed.2020.00057
  • Rebman, A. W., Bechtold, K. T., Yang, T., Mihm, E. A., Soloski, M. J., Novak, C. B., & Aucott, J. N. (2017). The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment Lyme disease syndrome. Frontiers in Medicine, 4, 224. doi: 10.3389/fmed.2017.00224
  • Scott, J. D., Clark, K. L., Foley, J. E., Anderson, J. F., Bierman, B. C., & Durden, L. A. (2018). Extensive distribution of the Lyme disease bacterium, Borrelia burgdorferi Sensu Lato, in multiple tick species parasitizing avian and mammalian hosts across Canada. Healthcare (Basel, Switzerland), 6(4), 131. https://doi.org/10.3390/healthcare6040131
  • Shor, W., Green C., Szantyr B., Phillips S., Liegner K., Burrascano J., Bransfield R., & Maloney W.L. (2019). Chronic Lyme disease: An evidence-based definition by the ILADS working group. Antibiotics, 8, 269. doi: 10.3390/antiobiotics8040269
  • Smith, G. N., Moore, K. M., Hatchette, T. F., Nicholson, J., Bowie, W., Langley, J. M. (2020). Committee opinion no.399: Management of tick bites and Lyme disease during pregnancy. Journal of Obstetrics and Gynaecology Canada, 42(5), 644.
  • Statistics Canada. (2019). Travel between Canada and other countries, December 2019. https://www150.statcan.gc.ca/n1/daily-quotidien/200221/dq200221b-eng.htm
  • Truth and Reconciliation Commission of Canada. (2015). Honouring the truth, reconciling for the future: Summary of the final report of the Truth and Reconciliation Commission of Canada. Truth and Reconciliation Commission of Canada. http://nctr.ca/assets/reports/Final%20Reports/Executive_Summary_English_Web.pdf
  • Waddell, L. A., Greig, J., Lindsay, L. R., Hinckley, A. F., & Ogden, N. H. (2018). A systematic review on the impact of gestational Lyme disease in humans on the fetus and newborn. PloS One, 13(11). doi: https://doi.org/10.1371/journal.pone.0207067
  • Ward, C., Branch, C., & Fridkin A. (2016). What is Indigenous cultural safety—and why should I care about it? Visions Journal, 11 (4). Retrieved from https://www.heretohelp.bc.ca/visions/indigenous-people-vol11/what-indigenous-cultural-safety-and-why-should-i-care-about-it#:~:text=This%20is%20the%20heart%20of,as%20these%20relate%20to%20Indigenous
  • World Health Organization [WHO]. (2020). WHOQOL: Measuring quality of life. Retrieved from https://www.who.int/toolkits/whoqol
  • World Health Organization. (n.d.). West Nile virus in the WHO European region. Retrieved from https://www.euro.who.int/__data/assets/pdf_file/0020/246170/Fact-sheet-West-Nile-virus-Eng.pdf
  • Wormser, G., Dattwyler, R., Shapiro, E., Halperin, J., Steere, A., Klempner, M., Krause, P., Bakken, J., Strle, F., Stanek, G., Bockenstedt, L., Fish, D., Dumler, S., & Nadelman, R. (2006). The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases, 43(9), 1089-1134. https://doi.org/10.1086/508667